Skip to main content
Top
Published in: AIDS Research and Therapy 1/2007

Open Access 01-12-2007 | Research

Perceptions of vaginal microbicides as an HIV prevention method among health care providers in KwaZulu-Natal, South Africa

Authors: Gita Ramjee, Neetha S Morar, James Mtimkulu, Joanne E Mantell, Varanna Gharbaharan

Published in: AIDS Research and Therapy | Issue 1/2007

Login to get access

Abstract

Background

The promise of microbicides as an HIV prevention method will not be realized if not supported by health care providers. They are the primary source of sexual health information for potential users, in both the public and private health sectors. Therefore, the aim of this study was to determine perceptions of vaginal microbicides as a potential HIV prevention method among health care providers in Durban and Hlabisa, South Africa, using a combination of quantitative and qualitative methods.

Results

During 2004, semi structured interviews with 149 health care providers were conducted. Fifty seven percent of hospital managers, 40% of pharmacists and 35% of nurses possessed some basic knowledge of microbicides, such as the product being used intra-vaginally before sex to prevent HIV infection. The majority of them were positive about microbicides and were willing to counsel users regarding potential use. Providers from both public and private sectors felt that an effective microbicide should be available to all people, regardless of HIV status. Providers felt that the product should be accessed over-the-counter in pharmacies and in retail stores. They also felt a need for potential microbicides to be available free of charge, and packaged with clear instructions. The media was seen by health care providers as being an effective strategy for promoting microbicides.

Conclusion

Overall, health care providers were very positive about the possible introduction of an effective microbicide for HIV prevention. The findings generated by this study illustrated the need for training health care providers prior to making the product accessible, as well as the importance of addressing the potential barriers to use of the product by women. These are important concerns in the health care community, and this study also served to educate them for the day when research becomes reality.
Appendix
Available only for authorised users
Literature
1.
go back to reference Feldblum PJ, Kuyoh MA, Bwayo JJ, Omari M, Wong EL, Tweedy KG, Welsh MJ: Female condom introduction and sexually transmitted infection prevalence: results of a community intervention trial in Kenya. AIDS. 2001, 15: 1037-1044. 10.1097/00002030-200105250-00012CrossRefPubMed Feldblum PJ, Kuyoh MA, Bwayo JJ, Omari M, Wong EL, Tweedy KG, Welsh MJ: Female condom introduction and sexually transmitted infection prevalence: results of a community intervention trial in Kenya. AIDS. 2001, 15: 1037-1044. 10.1097/00002030-200105250-00012CrossRefPubMed
2.
go back to reference Mantell JE, Scheepers E, Karim QA: Introducing the female condom through the public health sector: experiences from South Africa. AIDS Care. 2000, 12: 589-601. 10.1080/095401200750003770CrossRefPubMed Mantell JE, Scheepers E, Karim QA: Introducing the female condom through the public health sector: experiences from South Africa. AIDS Care. 2000, 12: 589-601. 10.1080/095401200750003770CrossRefPubMed
3.
go back to reference Mantell JE, Hoffman S, Weiss E, Adeokun L, Delano G, Jagha T, Exner TM, Stein ZA, Karim QA, Scheepers E, Atkins K, Weiss E: The acceptability of the female condom: perspectives of family planning providers in New York City, South Africa, and Nigeria. J Urban Health. 2001, 78: 658-668.PubMedCentralCrossRefPubMed Mantell JE, Hoffman S, Weiss E, Adeokun L, Delano G, Jagha T, Exner TM, Stein ZA, Karim QA, Scheepers E, Atkins K, Weiss E: The acceptability of the female condom: perspectives of family planning providers in New York City, South Africa, and Nigeria. J Urban Health. 2001, 78: 658-668.PubMedCentralCrossRefPubMed
4.
go back to reference Adeokun L, Mantell J, Weiss E, Delano GE, Jagha T, Olatoregun J, Udo D, Akinso S, Weiss E: Promoting dual protection in family planning clinics in Ibadan, Nigeria. Int Fam Plann Persp. 2002, 28: 87-95. 10.2307/3088240.CrossRef Adeokun L, Mantell J, Weiss E, Delano GE, Jagha T, Olatoregun J, Udo D, Akinso S, Weiss E: Promoting dual protection in family planning clinics in Ibadan, Nigeria. Int Fam Plann Persp. 2002, 28: 87-95. 10.2307/3088240.CrossRef
5.
go back to reference Morroni C, Smit J, McFayden L, Mqhayi M, Beksinska M: Dual protection against sexually transmitted infections and pregnancy in South Africa. African J Rep Health. 2003, 7: 13-19. 10.2307/3583208.CrossRef Morroni C, Smit J, McFayden L, Mqhayi M, Beksinska M: Dual protection against sexually transmitted infections and pregnancy in South Africa. African J Rep Health. 2003, 7: 13-19. 10.2307/3583208.CrossRef
6.
go back to reference Fairhurst K, Ziebland S, Wyke S, Seaman P, Glasier A: Emergency contraception: why can't you give it away? Qualitative findings from an evaluation of advance provision of emergency contraception. Contraception. 2004, 70: 25-29. 10.1016/j.contraception.2004.02.012CrossRefPubMed Fairhurst K, Ziebland S, Wyke S, Seaman P, Glasier A: Emergency contraception: why can't you give it away? Qualitative findings from an evaluation of advance provision of emergency contraception. Contraception. 2004, 70: 25-29. 10.1016/j.contraception.2004.02.012CrossRefPubMed
7.
go back to reference Espinoza H, Abuabara K, Ellertson C: Physicians' knowledge and opinions about medication abortion in four Latin American and Caribbean region countries. Contraception. 2004, 70: 127-133. 10.1016/j.contraception.2004.03.011CrossRefPubMed Espinoza H, Abuabara K, Ellertson C: Physicians' knowledge and opinions about medication abortion in four Latin American and Caribbean region countries. Contraception. 2004, 70: 127-133. 10.1016/j.contraception.2004.03.011CrossRefPubMed
8.
go back to reference Syahlul DE, Amir LH: Do Indonesian medical practitioners approve the availability of emergency contraception over-the-counter? A survey of general practitioners and obstetricians in Jakarta. BMC Womens Health. 2005, 5: 3- 10.1186/1472-6874-5-3PubMedCentralCrossRefPubMed Syahlul DE, Amir LH: Do Indonesian medical practitioners approve the availability of emergency contraception over-the-counter? A survey of general practitioners and obstetricians in Jakarta. BMC Womens Health. 2005, 5: 3- 10.1186/1472-6874-5-3PubMedCentralCrossRefPubMed
9.
go back to reference Kiapi-Iwa L, Hart GJ: The sexual and reproductive health of young people in Adjumani district, Uganda: qualitative study of the role of formal, informal and traditional health providers. AIDS Care. 2004, 16: 339-347. 10.1080/09540120410001665349CrossRefPubMed Kiapi-Iwa L, Hart GJ: The sexual and reproductive health of young people in Adjumani district, Uganda: qualitative study of the role of formal, informal and traditional health providers. AIDS Care. 2004, 16: 339-347. 10.1080/09540120410001665349CrossRefPubMed
10.
go back to reference Mantell JE, Myer L, Dieguez AC, Stein Z, Ramjee G, Morar NS, Harrison PF: Microbicide acceptability: current approaches and future directions. Soc Sci Med. 2005, 60: 319-330. 10.1016/j.socscimed.2004.05.011CrossRefPubMed Mantell JE, Myer L, Dieguez AC, Stein Z, Ramjee G, Morar NS, Harrison PF: Microbicide acceptability: current approaches and future directions. Soc Sci Med. 2005, 60: 319-330. 10.1016/j.socscimed.2004.05.011CrossRefPubMed
11.
go back to reference Low-Beer S, Weber AE, Bartholomew K, Landolt M, Oram D, Montaner JSG, O'Shaughnessy MV, Hogg RS: A reality check: the cost of making post-exposure prophylaxis available to gay and bisexual men at high sexual risk. AIDS. 2000, 14: 325-326. 10.1097/00002030-200002180-00017CrossRefPubMed Low-Beer S, Weber AE, Bartholomew K, Landolt M, Oram D, Montaner JSG, O'Shaughnessy MV, Hogg RS: A reality check: the cost of making post-exposure prophylaxis available to gay and bisexual men at high sexual risk. AIDS. 2000, 14: 325-326. 10.1097/00002030-200002180-00017CrossRefPubMed
12.
go back to reference Darroch JE, Frost JJ: Women's interest in vaginal microbicides. Fam Plann Persp. 1999, 31: 16-23. 10.2307/2991552.CrossRef Darroch JE, Frost JJ: Women's interest in vaginal microbicides. Fam Plann Persp. 1999, 31: 16-23. 10.2307/2991552.CrossRef
13.
go back to reference Watts C, Vickermann P: The impact of microbicides on HIV and STD transmission: model projections. AIDS. 2001, 15: S43-S44. 10.1097/00002030-200102001-00064.CrossRef Watts C, Vickermann P: The impact of microbicides on HIV and STD transmission: model projections. AIDS. 2001, 15: S43-S44. 10.1097/00002030-200102001-00064.CrossRef
14.
go back to reference Orner P, Harries J, Cooper D, Moodley J, Hoffman M, Becker J, McGrory E, Dabash R, Bracken H: Challenges to microbicide introduction in South Africa. Soc Sci Med. 2006, 63: 968-978. 10.1016/j.socscimed.2006.02.019CrossRefPubMed Orner P, Harries J, Cooper D, Moodley J, Hoffman M, Becker J, McGrory E, Dabash R, Bracken H: Challenges to microbicide introduction in South Africa. Soc Sci Med. 2006, 63: 968-978. 10.1016/j.socscimed.2006.02.019CrossRefPubMed
Metadata
Title
Perceptions of vaginal microbicides as an HIV prevention method among health care providers in KwaZulu-Natal, South Africa
Authors
Gita Ramjee
Neetha S Morar
James Mtimkulu
Joanne E Mantell
Varanna Gharbaharan
Publication date
01-12-2007
Publisher
BioMed Central
Published in
AIDS Research and Therapy / Issue 1/2007
Electronic ISSN: 1742-6405
DOI
https://doi.org/10.1186/1742-6405-4-7

Other articles of this Issue 1/2007

AIDS Research and Therapy 1/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.